310 related articles for article (PubMed ID: 35326338)
1. Ketamine as a Novel Psychopharmacotherapy for Eating Disorders: Evidence and Future Directions.
Ragnhildstveit A; Slayton M; Jackson LK; Brendle M; Ahuja S; Holle W; Moore C; Sollars K; Seli P; Robison R
Brain Sci; 2022 Mar; 12(3):. PubMed ID: 35326338
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature.
Martinotti G; Chiappini S; Pettorruso M; Mosca A; Miuli A; Di Carlo F; D'Andrea G; Collevecchio R; Di Muzio I; Sensi SL; Di Giannantonio M
Brain Sci; 2021 Jun; 11(7):. PubMed ID: 34199023
[TBL] [Abstract][Full Text] [Related]
3. Improvement in depressive symptoms in a patient with severe and enduring anorexia nervosa and comorbid major depressive disorder using psychotherapy-assisted IV ketamine : a case report.
Timek A; Daniels-Brady C; Ferrando S
J Eat Disord; 2024 Jun; 12(1):79. PubMed ID: 38867336
[TBL] [Abstract][Full Text] [Related]
4. The potential of ketamine for posttraumatic stress disorder: a review of clinical evidence.
Ragnhildstveit A; Roscoe J; Bass LC; Averill CL; Abdallah CG; Averill LA
Ther Adv Psychopharmacol; 2023; 13():20451253231154125. PubMed ID: 36895431
[TBL] [Abstract][Full Text] [Related]
5. Network analysis of specific psychopathology and psychiatric symptoms in patients with eating disorders.
Solmi M; Collantoni E; Meneguzzo P; Degortes D; Tenconi E; Favaro A
Int J Eat Disord; 2018 Jul; 51(7):680-692. PubMed ID: 29846016
[TBL] [Abstract][Full Text] [Related]
6. Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review.
Keeler JL; Treasure J; Juruena MF; Kan C; Himmerich H
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836413
[TBL] [Abstract][Full Text] [Related]
7. Case Report: Unexpected Remission From Extreme and Enduring Bulimia Nervosa With Repeated Ketamine Assisted Psychotherapy.
Ragnhildstveit A; Jackson LK; Cunningham S; Good L; Tanner Q; Roughan M; Henrie-Barrus P
Front Psychiatry; 2021; 12():764112. PubMed ID: 34867548
[No Abstract] [Full Text] [Related]
8. Molecular bases of anorexia nervosa, bulimia nervosa and binge eating disorder: shedding light on the darkness.
Cuesto G; Everaerts C; León LG; Acebes A
J Neurogenet; 2017 Dec; 31(4):266-287. PubMed ID: 28762842
[TBL] [Abstract][Full Text] [Related]
9. Case report: Intramuscular ketamine or intranasal esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa.
Keeler JL; Treasure J; Himmerich H; Brendle M; Moore C; Robison R
Front Psychiatry; 2023; 14():1181447. PubMed ID: 37255674
[TBL] [Abstract][Full Text] [Related]
10. An updated transdiagnostic review of social cognition and eating disorder psychopathology.
Mason TB; Lesser EL; Dolgon-Krutolow AR; Wonderlich SA; Smith KE
J Psychiatr Res; 2021 Nov; 143():602-627. PubMed ID: 33190838
[TBL] [Abstract][Full Text] [Related]
11. The Opioid System and Food Intake: Use of Opiate Antagonists in Treatment of Binge Eating Disorder and Abnormal Eating Behavior.
Valbrun LP; Zvonarev V
J Clin Med Res; 2020 Feb; 12(2):41-63. PubMed ID: 32095174
[TBL] [Abstract][Full Text] [Related]
12. Psychiatric comorbidity in anorexia and bulimia nervosa: nature, prevalence, and causal relationships.
O'Brien KM; Vincent NK
Clin Psychol Rev; 2003 Feb; 23(1):57-74. PubMed ID: 12559994
[TBL] [Abstract][Full Text] [Related]
13. Psychotherapy for bulimia nervosa and binging.
Hay PJ; Bacaltchuk J
Cochrane Database Syst Rev; 2003; (1):CD000562. PubMed ID: 12535397
[TBL] [Abstract][Full Text] [Related]
14. Suicide attempts in US adults with lifetime DSM-5 eating disorders.
Udo T; Bitley S; Grilo CM
BMC Med; 2019 Jun; 17(1):120. PubMed ID: 31234891
[TBL] [Abstract][Full Text] [Related]
15. Obsessive-compulsive symptoms in female patients with an eating disorder with or without impulsive non-suicidal self-injury.
Claes L; Buelens T; Depestele L; Dierckx E; Schoevaerts K; Luyckx K
Eur Eat Disord Rev; 2021 Jul; 29(4):663-669. PubMed ID: 33880819
[TBL] [Abstract][Full Text] [Related]
16. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
[TBL] [Abstract][Full Text] [Related]
17. Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.
Hashimoto K
Psychiatry Clin Neurosci; 2019 Oct; 73(10):613-627. PubMed ID: 31215725
[TBL] [Abstract][Full Text] [Related]
18. A controlled family study of anorexia nervosa and bulimia nervosa: psychiatric disorders in first-degree relatives and effects of proband comorbidity.
Lilenfeld LR; Kaye WH; Greeno CG; Merikangas KR; Plotnicov K; Pollice C; Rao R; Strober M; Bulik CM; Nagy L
Arch Gen Psychiatry; 1998 Jul; 55(7):603-10. PubMed ID: 9672050
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacology of ketamine and esketamine as rapid-acting antidepressants].
Pavlidi P; Megalokonomou A; Sofron A; Kokras N; Dalla C
Psychiatriki; 2021 Dec; 32(Supplement I):55-63. PubMed ID: 34990380
[TBL] [Abstract][Full Text] [Related]
20. Stigmatization toward People with Anorexia Nervosa, Bulimia Nervosa, and Binge Eating Disorder: A Scoping Review.
Brelet L; Flaudias V; Désert M; Guillaume S; Llorca PM; Boirie Y
Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
